{"Ticker": "PEAK", "Company": "Healthpeak Properties", "Sector": "Real Estate", "Updated": "2021-12-30 12:12:24", "Rating": [{"Date": "2021-12-20", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$38 to $40"}, {"Date": "2021-12-06", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform", "Target_Change": ""}, {"Date": "2021-07-14", "Rating": "Resumed", "Organization": "Mizuho", "Rating_Change": "Neutral", "Target_Change": "$32"}, {"Date": "2021-05-20", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$34"}, {"Date": "2021-03-30", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Buy", "Target_Change": "$34 to $35.50"}, {"Date": "2021-01-20", "Rating": "Upgrade", "Organization": "CapitalOne", "Rating_Change": "Equal Weight to Overweight", "Target_Change": ""}, {"Date": "2020-12-14", "Rating": "Downgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight to Sector Weight", "Target_Change": ""}, {"Date": "2020-12-10", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Underweight", "Target_Change": "$26 to $25"}, {"Date": "2020-10-16", "Rating": "Downgrade", "Organization": "Mizuho", "Rating_Change": "Buy to Neutral", "Target_Change": "$29"}, {"Date": "2020-09-02", "Rating": "Resumed", "Organization": "Stifel", "Rating_Change": "Buy", "Target_Change": "$31"}, {"Date": "2020-04-29", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": ""}, {"Date": "2020-03-23", "Rating": "Downgrade", "Organization": "BofA/Merrill", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2019-12-20", "Rating": "Initiated", "Organization": "Mizuho", "Rating_Change": "Buy", "Target_Change": ""}, {"Date": "2019-10-08", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$35 to $38"}, {"Date": "2019-09-10", "Rating": "Upgrade", "Organization": "Argus", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2019-09-03", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$37"}, {"Date": "2019-06-13", "Rating": "Upgrade", "Organization": "Raymond James", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": ""}, {"Date": "2019-01-07", "Rating": "Upgrade", "Organization": "Robert W. Baird", "Rating_Change": "Neutral to Outperform", "Target_Change": ""}, {"Date": "2018-12-20", "Rating": "Upgrade", "Organization": "KeyBanc Capital Mkts", "Rating_Change": "Sector Weight to Overweight", "Target_Change": ""}, {"Date": "2018-11-02", "Rating": "Upgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform to Outperform", "Target_Change": ""}]}